Skip to main content
. 2022 May 26;12:212. doi: 10.1038/s41398-022-01968-0

Fig. 1. Significantly changed IRFs in SCZ or (and) BPD between acute episode and remission.

Fig. 1

A CD30 and BAFF expression were increased in SCZ patients after treatment (N = 42 pairs); B CD30, BAFF, and CCL20 expression were increased in BPD patients after treatment (N = 41 pairs); C CD30, BAFF, CCL20, and CXCL10 expression were increased in the total psychosis (SCZ+BPD) patients after treatment (N = 83 pairs). Paired t tests were completed to test for statistical significance and Bonferroni correction was performed for multiple comparisons in different groups. (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001). SCZ schizophrenia; BPD bipolar disorder.